Anzeige
Mehr »
Donnerstag, 04.09.2025 - Börsentäglich über 12.000 News
Set to Action: Q-Gold vor drastischer Neubewertung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40LMS | ISIN: US80303D3052 | Ticker-Symbol:
NASDAQ
04.09.25 | 15:30
39,000 US-Dollar
+0,18 % +0,070
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SANUWAVE HEALTH INC Chart 1 Jahr
5-Tage-Chart
SANUWAVE HEALTH INC 5-Tage-Chart

Aktuelle News zur SANUWAVE HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiSANUWAVE Health stock initiated with Outperform rating at Northland1
22.08.SANUWAVE Health, Inc. - S-8, Securities to be offered to employees in employee benefit plans2
22.08.Sanuwave Health rises after $5M payment related to patent sale1
20.08.SANUWAVE Health, Inc. - 8-K, Current Report2
11.08.Roth/MKM raises SANUWAVE Health stock price target to $54 on margin strength1
08.08.SANUWAVE outlines Q3 revenue target of $12M-$12.7M as new applicator production nears launch1
SANUWAVE HEALTH Aktie jetzt für 0€ handeln
08.08.SANUWAVE Q2 2025 presentation: 42% revenue growth drives stock surge2
08.08.SANUWAVE-Aktie steigt nach starken Q2-Zahlen und Umsatzplus3
08.08.SANUWAVE Health GAAP EPS of $0.01 beats by $0.10, revenue of $10.2M beats by $0.06M1
08.08.SANUWAVE Health Inc. Profit Declines In Q2-
08.08.SANUWAVE Health, Inc. - 8-K, Current Report1
08.08.SANUWAVE Health, Inc.: Sanuwave Announces Q2 FY2025 Financial Results106Q2 2025 revenues were $10.2 million, up 42% from $7.2 million in Q2 2024. This represents the highest Q2 quarterly revenues in Company history. Q2 2025 gross margin was 78.3%, versus 73.2% in Q2 2024....
► Artikel lesen
07.08.SANUWAVE Health, Inc. - 10-Q, Quarterly Report3
06.08.Preview: SANUWAVE Health's Earnings1
31.07.SANUWAVE Health, Inc. - 8-K, Current Report2
30.07.Sanuwave Health is a buy, Roth Capital says2
29.07.Roth/MKM initiates SANUWAVE Health stock with Buy rating, cites growth potential1
14.07.SANUWAVE Health, Inc.: Sanuwave Health Announces Preliminary Revenue Results for the Second Quarter 2025 (Ended June 30, 2025)65Sanuwave is pleased to announce preliminary revenues of $10.1 million to $10.2 million for the second quarter ended June 30, 2025. This represents the highest Q2 quarterly revenues in Company history....
► Artikel lesen
14.07.SANUWAVE Health, Inc. - 8-K, Current Report1
26.06.SANUWAVE Health, Inc. - 8-K, Current Report4
Weiter >>
44 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1